These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28664217)

  • 1. Impairment Experiences, Identity and Attitudes Towards Genetic Screening: the Views of People with Spinal Muscular Atrophy.
    Boardman FK; Young PJ; Griffiths FE
    J Genet Couns; 2018 Feb; 27(1):69-84. PubMed ID: 28664217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of experiential knowledge within attitudes towards genetic carrier screening: A comparison of people with and without experience of spinal muscular atrophy.
    Boardman FK; Young PJ; Warren O; Griffiths FE
    Health Expect; 2018 Feb; 21(1):201-211. PubMed ID: 28703871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families.
    Boardman FK; Young PJ; Griffiths FE
    Am J Med Genet A; 2017 Feb; 173(2):421-434. PubMed ID: 27792846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for spinal muscular atrophy: The views of affected families and adults.
    Boardman FK; Young PJ; Griffiths FE
    Am J Med Genet A; 2017 Jun; 173(6):1546-1561. PubMed ID: 28374951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes.
    Moultrie RR; Kish-Doto J; Peay H; Lewis MA
    J Genet Couns; 2016 Oct; 25(5):892-900. PubMed ID: 27084745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current attitudes toward carrier screening for spinal muscular atrophy among pregnant women in Eastern China.
    Li Y; Wang L; Tan J; Huang M; Wang Y; Shao B; Lv J; Zhang J
    J Genet Couns; 2023 Aug; 32(4):823-832. PubMed ID: 36775845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to Pay for a Newborn Screening Test for Spinal Muscular Atrophy.
    Lin PJ; Yeh WS; Neumann PJ
    Pediatr Neurol; 2017 Jan; 66():69-75. PubMed ID: 27769729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.
    Qian Y; McGraw S; Henne J; Jarecki J; Hobby K; Yeh WS
    BMC Neurol; 2015 Oct; 15():217. PubMed ID: 26499462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
    Pacione M; Siskind CE; Day JW; Tabor HK
    J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn and carrier screening for spinal muscular atrophy.
    Prior TW; Snyder PJ; Rink BD; Pearl DK; Pyatt RE; Mihal DC; Conlan T; Schmalz B; Montgomery L; Ziegler K; Noonan C; Hashimoto S; Garner S
    Am J Med Genet A; 2010 Jul; 152A(7):1608-16. PubMed ID: 20578137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Carrier Screening for Spinal Muscular Atrophy.
    Wood SL; Brewer F; Ellison R; Biggio JR; Edwards RK
    Am J Perinatol; 2016 Oct; 33(12):1211-7. PubMed ID: 27611803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public attitudes regarding a pilot study of newborn screening for spinal muscular atrophy.
    Rothwell E; Anderson RA; Swoboda KJ; Stark L; Botkin JR
    Am J Med Genet A; 2013 Apr; 161A(4):679-86. PubMed ID: 23443997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mixed methods exploration of families' experiences of the diagnosis of childhood spinal muscular atrophy.
    Lawton S; Hickerton C; Archibald AD; McClaren BJ; Metcalfe SA
    Eur J Hum Genet; 2015 May; 23(5):575-80. PubMed ID: 25074464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for spinal muscular atrophy: Anticipating an imminent need.
    Phan HC; Taylor JL; Hannon H; Howell R
    Semin Perinatol; 2015 Apr; 39(3):217-29. PubMed ID: 25979781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving approaches to prenatal genetic counseling for Spinal Muscular Atrophy in the new treatment era.
    Zettler B; Estrella E; Liaquat K; Lichten L
    J Genet Couns; 2022 Jun; 31(3):803-814. PubMed ID: 35037741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows.
    Milligan JN; Blasco-Pérez L; Costa-Roger M; Codina-Solà M; Tizzano EF
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal Muscular Atrophy: Inheritance, Screening, and Counseling for the Obstetric Provider.
    Hopkins MK; Dugoff L; Kuller JA
    Obstet Gynecol Surv; 2021 Mar; 76(3):166-169. PubMed ID: 33783545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.
    Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M
    Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.